The independent source for health policy research, polling, and news.
941-960 of 113,253 results
FiercePharma reports on how Shionogi’s oral antiviral drug — sold under the name Xocova and available in Japan since 2022 — has been cleared by the FDA for post-exposure prophylaxis for U.S. adults and some adolescents who have been exposed to covid. This makes it the first post-exposure covid oral drug approved in the United States.
The Bundibugyo strain of the Ebola virus has no targeted vaccine or therapeutics, CIDRAP reports. Experts say that the outbreak, which is already the third-largest in history, is likely much worse than official numbers suggest.
The guidance to states indicates pregnant women, parents of young children, veterans with disabilities, and people who are “medically frail” are among the Medicaid enrollees who may be exempt from work requirements, but not people who are homeless, NBC reports. Also: The Trump administration has been blocked from removing currently enlisted transgender service members.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these topics and others.
Emails and records released by the Justice Department indicate Epstein had been banking his DNA for at least several years, but it's unclear whether it is still being preserved, The New York Times reported. One law expert told The Times that the issue of whether it is ethical for a facility to accept sperm from a sex offender is an ongoing debate in the fertility industry.
Results of the long-awaited clinical trial of the drug daraxonrasib were presented Sunday at the American Society of Clinical Oncology’s meeting in Chicago. “Unprecedented,” “compelling,” and “spectacular” are some of the words being used to describe the results, The Washington Post reports.
The FDA expanded the approved use for the inhaled insulin drug Afrezza on Friday. ABC News reports it is now approved for kids 6 years and older with Type 1 diabetes or those who require insulin with Type 2 diabetes. Plus: AI use as a diagnostic tool; Massachusetts vs. UnitedHealthcare in alleged Medicaid fraud case; and more.
Meta, TikTok, Snap Inc., and YouTube all settled with Kentucky's Breathitt County School District, avoiding a trial, Bloomberg reports, adding that more than 1,300 other school districts have filed similar lawsuits and are awaiting trial.
“Protecting Kenyans requires more than hoping diseases do not cross our borders,” the nation's Health Ministry said in a statement over the weekend. Kenyan health officials said Sunday that the facility is for "everyone," not just Americans. Plus: Suspected Ebola cases in Brazil and Italy are being investigated; the recovery of five patients prompts hope; and more.
In an executive order on Friday, President Donald Trump endorsed the new schedule, which reduces the number of recommended childhood vaccinations from 17 to 11, The Hill reports. Meanwhile, ProPublica reports on how efforts to combat gun violence have changed under the Trump administration.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on 911 dispatchers, suntans, longevity, and more.
The cohort study found that Alzheimer's pathology can be detected in midlife in about 6% of adults. The changes are detected via blood markers and are linked to subtle cognitive differences. Also: The FDA relaxes oversight on blood pressure wearables.
Wednesday's ruling blocks a Van Buren Township landfill from receiving the radioactive waste. Republic Services owns the waste facility and plans to appeal the decision. The site "is specifically engineered to handle ... complex waste streams," a spokesperson said.
Also, the U.S. government will allow American cruise ship passengers exposed to the hantavirus to return home as early as Monday, but they must remain under constant state supervision for the remaining three weeks of their six-week quarantine.
The Trump administration had reached an agreement with the Kenyan government that would have allowed Americans exposed to the deadly virus to isolate in the East African nation. A human rights groups contends the plan poses “grave health risks” to the public, Bloomberg reports. The Kenyan judge will hear arguments in the case June 2.
The Vaccines and Related Biological Products Advisory Committee also discussed the "cicada" variant but in the end decided to focus on the current dominant strain.
Although the rate has held steady for the past few years, Modern Healthcare reports the nonpartisan Congressional Budget Office projects 10 million people will lose coverage over the next decade due to changes in health programs instituted by the Trump administration.
© 2026 KFF